A number of firms have modified their ratings and price targets on shares of Molina Healthcare (NYSE: MOH) recently:

  • 8/9/2017 – Molina Healthcare had its “hold” rating reaffirmed by analysts at Deutsche Bank AG. They now have a $72.00 price target on the stock.
  • 8/7/2017 – Molina Healthcare was downgraded by analysts at TheStreet from a “b” rating to a “c” rating.
  • 8/4/2017 – Molina Healthcare was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating.
  • 7/28/2017 – Molina Healthcare was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.
  • 7/17/2017 – Molina Healthcare was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Molina Healthcare suffers from rising medical care costs along with acute dependence on debt financing that has resulted in higher interest expenses draining the bottom line. The Zacks Consensus earnings estimate for both 2017 and 2018 has declined significantly over past 90 days. However, year to date, the shares have gained 29% outperforming the Zacks classified Health Maintenance Organization that increased 21%. The company has been witnessing steady increase in premiums and service revenues over the past several quarters. Its several inorganic growth initiatives have paid off well. It will release the second quarter results On Aug 2, 2017. The Zacks Consensus Estimate is pegged at $0.86 for the second quarter reflecting a 29% year over year growth.”
  • 7/14/2017 – Molina Healthcare had its “underperform” rating reaffirmed by analysts at Credit Suisse Group. They now have a $53.00 price target on the stock, up previously from $50.00.
  • 7/14/2017 – Molina Healthcare had its price target raised by analysts at Bank of America Corporation from $59.00 to $60.00. They now have an “underperform” rating on the stock.
  • 7/14/2017 – Molina Healthcare had its “hold” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $72.00 price target on the stock.
  • 7/14/2017 – Molina Healthcare had its “sell” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $60.00 price target on the stock.
  • 7/11/2017 – Molina Healthcare was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating.
  • 7/11/2017 – Molina Healthcare was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Molina Healthcare suffers from rising medical care costs along with acute dependence on debt financing that has resulted in higher interest expenses draining the bottom line. Donald Trump’s decision of replacing the ObamaCare Act has resulted in an uncertain future of health care sector. The Zacks Consensus earnings estimate for both 2017 and 2018 has declined significantly over past 90 days. However, year to date, the shares gained 29% outperforming the Zacks classified Health Maintenance Organization that increased 21%. The company has been witnessing steady increase in premiums and service revenues over the past several quarters. Its several inorganic growth initiatives have paid off well. It will release the second quarter results On Aug 2, 2017. The Zacks Consensus Estimate is pegged at $0.86 for the second quarter reflecting a 29% year over year growth.”

Shares of Molina Healthcare Inc (NYSE:MOH) traded up 0.230% during midday trading on Wednesday, hitting $58.735. The company had a trading volume of 180,667 shares. Molina Healthcare Inc has a 12 month low of $42.56 and a 12 month high of $72.79. The company has a 50-day moving average of $69.33 and a 200 day moving average of $58.95. The firm’s market capitalization is $3.29 billion.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, August 2nd. The company reported ($0.01) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.86 by $0.87. Molina Healthcare had a negative net margin of 1.07% and a positive return on equity of 16.10%. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.88 billion. During the same period in the previous year, the firm posted $0.67 earnings per share. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. On average, analysts expect that Molina Healthcare Inc will post $2.20 EPS for the current fiscal year.

In related news, insider William Dentino sold 66,000 shares of the business’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $60.09, for a total transaction of $3,965,940.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John C. Molina sold 21,277 shares of the business’s stock in a transaction on Tuesday, July 18th. The stock was sold at an average price of $70.53, for a total value of $1,500,666.81. Following the transaction, the director now directly owns 611,154 shares of the company’s stock, valued at $43,104,691.62. The disclosure for this sale can be found here. Insiders have sold a total of 253,134 shares of company stock valued at $16,745,242 over the last three months. 6.20% of the stock is currently owned by insiders.

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.